Cargando…
The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A
Background: Patients with chronic spontaneous urticaria (CSU), an autoimmune disorder, show increased skin expression of IL-17A and can benefit from treatment with the anti-IL-17A biologic secukinumab. The mechanisms that drive IL-17A expression in CSU are currently unknown, but may involve Semaphor...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998863/ https://www.ncbi.nlm.nih.gov/pubmed/33801296 http://dx.doi.org/10.3390/biom11030373 |